Fasinumab topline phase III data presented in patients with chronic pain from OA of the knee or hip Aug. 17, 2018
Izana Bioscience begins phase II proof-of-concept study of namilumab in ankylosing spondylitis Aug. 14, 2018
OrthoTrophix presents phase II results for TPX-100 in patients with knee osteoarthritis Aug. 14, 2018